The Wake Forest Organoid Research Center (WFORCE), is a joint effort between the Wake Forest Institute for Regenerative Medicine and the Wake Forest Comprehensive Cancer Center and brings together researchers and clinicians, who are working side by side, to leverage the use of tissue organoid technology for the benefit of our patients.

The Core Mission is bold — to Redesign Cancer Care.


WFORCE is the first program of its kind, to leverage reconstruction of each patient's own tumor in the form of 3D patient-specific tumor organoids and apply it translationally, with a goal of informing personalized treatment of cancer, as well as research and development of new therapies.